Translated automatically – community improvements welcome.

Nimodipine

Nimodipine is a selective L-type calcium channel blocker from the group of dihydropyridines, primarily used for the dilation of cerebral blood vessels. It is commonly used for the treatment and prevention of cerebral vasospasms following subarachnoid hemorrhages. The substance improves blood flow in the brain and exhibits neuroprotective properties. Side effects are usually mild and include headaches and hypotension.

Calciumkanalblocker

Mechanism of Action

L-Typ Calciumkanalblocker

Detailed mechanism of action

Names / Identifiers

IUPAC: Nimodipine

nimodipine

66085-59-4

Nimotop

Periplum

Admon

Nimodipino

Nymalize

Nimodipinum

BAY e 9736

Bay-e-9736

Effects

Vasodilatation

Verbesserung der zerebralen Durchblutung

Neuroprotektion

Senkung des Blutdrucks

Reduktion von zerebralen Vasospasmen

Effects described from scientific sources. Individual experiences vary.

Dosage

Safety NoteIndividual variation, start at a low dose, no medical advice.

Individual sensitivity varies. Not a dosage recommendation.

Duration

Peak2-4 hours

NotesDuration of action may vary depending on individual response.

Onset1-2 hours

Total6-8 hours

After EffectsMild, variable

Risks & Warnings

Warnings

Severe hypotension
Heart block

Known Risks

medium
Mögliche Nebenwirkungen umfassen Kopfschmerzen, Schwindel und Hypotonie.

Safer Use

Start at a low dose.
Regular monitoring of blood pressure values.

Harm reduction tips do not replace medical advice.

Known Interactions

May interact with other antihypertensive medications.

This list is not exhaustive. Interactions can have unpredictable effects.

Legal Status

ATVerschreibungspflichtig

CHVerschreibungspflichtig

DEVerschreibungspflichtig

USVerschreibungspflichtig

NotesNimodipine ist in vielen Ländern rezeptpflichtig und wird hauptsächlich im Krankenhaus verwendet.

Not legal advice. Status may change.